A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy

Journal of Clinical Investigation

Volumn 102, Issue 7, 1998, Pages 1292-1300

  Yang, Qinglin ^a   Sanbe, Atsushi ^a   Osinska, Hanna ^a   Hewett, Timothy E ^a   Klevitsky, Raisa ^a   Robbins, Jeffrey ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Cardiomyopathy; Heart; Hypertrophy; Mouse; Transgenic

Indexed keywords

BINDING PROTEIN; CALCIUM ION; COMPLEMENTARY DNA; MYOSIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; GENETIC DISORDER; HEART MUSCLE BIOPSY; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMERE; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0032189352     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3880     Document Type: Article

References (38)

1. Maron, B.J. 1996. Triggers for sudden cardiac death in the athlete. Card. Clinics. 14:195-210.
2. Geisterfer-Lowrance, A.A., S. Kass, G. Tanigawa, H.P. Vosberg, W. McKenna, C.E. Seidman, and J.G. Seidman. 1990. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 62:999-1006.
3. Bonne, G., L. Carrier, J. Bercovici, C. Cruaud, P. Richard, B. Hainque, M. Gautel, S. Labeit, M. James, J. Beckmann, et al. 1995. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat. Genet. 11:438-440.
4. Kimura, A., H. Harada, J.-E. Park, H. Nishi, M. Satob, M. Takahashi, S. Hiroi, T. Sasaoka, N. Ohbuchi, T. Nakamura, et al. 1997. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat. Genet. 16:379-382.
5. Poetter, K., H. Jiang, S. Hassanzadeh, S.R. Master, A. Chang, M.C. Dalakas, I. Rayment, J.R. Sellers, L. Fananapazir, and N.D. Epstein. 1996. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat. Genet. 13:63-69.
6. Thierfelder, L., H. Watkins, C. MacRae, R. Lamas, W. McKenna, H.P. Vosberg, J.G. Seidman, and C.E. Seidman. 1994. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 77:701-712.
7. Watkins, H., W.J. McKenna, L. Thierfelder, H.J. Suk, R. Anan, A. O'Donoghue, P. Spirito, A. Matsumori, C.S. Moravec, J.G. Seidman, and C.E. Seidman. 1995. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332:1058-1064.
8. MacRae, C.A., N. Ghaisas, S. Kass, S. Donnelly, C.T. Basson, H.C. Watkins, R. Anan, L.H. Thierfelder, K. McGarry, and E.E.A. Rowland. 1995. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J. Clin. Invest. 96:1216-1220.
9. Trinick, J. 1996. Titin as a scaffold and spring. Cytoskeleton. Curr. Biol. 6:258-260.
10. Offer, G., C. Moos, and R. Starr. 1973. A new protein of the thick filaments of vertebrate skeletal myofibrils. Extraction, purification and characterization. J. Mol. Biol. 74:653-676.
11. Freiburg, A., and M. Gautel. 1996. A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur. J. Biochem. 235:317-323.
12. Seiler, S.H., D.A. Fischman, and L.A. Leinwand. 1996. Modulation of myosin filament organization by c-protein family members. Mol Biol. Cell. 7: 113-127.
13. Watkins, H., D. Conner, L. Thierfelder, J.A. Jarcho, C. MacRae, W.J. McKenna, B.J. Maron, J.G. Seidman, and C.E. Seidman. 1995. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat. Genet. 11:434-437.
14. Yu, B., J.A. French, L. Carrier, R.W. Jeremy, D.R. McTaggart, M.R. Nicholson, B. Hambly, C. Semsarian, D.R. Richmond, K. Schwartz, and R.J. Trent. 1998. Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene. J. Med. Genet. 35:205-210.
15. Moolman-Smook, J.C., B. Mayosi, P. Brink, and V.A. Corfieid. 1998. Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy. J. Med. Genet. 35:253-254.
16. Carrier, L., G. Bonne, E. Bahrend, B. Yu, P. Richard, F. Niel, B. Hainque, C. Cruaud, F. Gary, S. Labeit, et al. 1997. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ. Res. 80:427-434.
17. Gilbert, R., M.G. Kelly, T. Mikawa, and D.A. Fischman. 1996. The carboxyl terminus of myosin binding protein C (MyBP-C, C-protein) specifies incorporation into the A-band of striated muscle. J. Cell Sci. 109:101-111.
18. Okagaki, T., F.E. Weber, D.A. Fischman, K.T. Vaughan, T. Mikawa, and F.C. Reinach. 1993. The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif. J. Cell Biol. 123:619-626.
19. Sweitzer, N.K., and R.L. Moss. 1993. Determinants of loaded shortening velocity in single cardiac myocytes permeabilized with alpha-hemolysin. Circ. Res. 73:1150-1162.
20. Schwartz, K. 1995. Familial hypertrophic cardiomyopathy. Nonsense versus missense mutations. Circulation. 91:2865-2867.
21. Rottbauer, W., M. Gautel, J. Zehelein, S. Labeit, W.M. Franz, C. Fischer, B. Vollrath, G. Mall, R. Dietz, W. Kubier, and H.A. Katus. 1997. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy.J. Clin. Invest. 100:475-482.
22. Kasahara, H., M. Itoh, T. Sugiyama, N. Kido, H. Hayashi, H. Saito, S. Tsukita, and N. Kato. 1994. Autoimmune myocarditis induced in mice by cardiac C-protcin. Cloning of complementary DNA encoding murine cardiac C-protein and partial characterization of the antigenic peptides.J. Clin. Invest. 94:1026-1036.
23. Palermo, J., J. Gulick, M. Colbert, J. Fewell, and J. Robbins. 1996. Transgenic remodeling of the contractile apparatus in the mammalian heart. Circ. Res. 78:504-509.
24. McAuliffe, J.J., and J. Robbins. 1991. Troponin T expression in normal and pressure-loaded fetal sheep heart. Pediatr. Res. 29:580-585.
25. Fewell, J., T.E. Hewett, R. Klevitsky, E. Hayes, D. Warshaw, A. Sanbe, D. Maughan, and J. Robbins. 1998. Functional significance of cardiac myosin essential light chain isoform switching in transgenic mice. J. Clin. Invest. 101:2639-2651.
26. Edman, K.A.P. 1979. The velocity of unloaded shortening and its relation to sarcomere length and isometric force in vertebrate muscle fibers. J. Physiol. 291:143-159.
27. Moss, R. 1986. Effects on shortening velocity of rabbit skeletal muscle due to variations in the level of thin-filament activation. J. Physiol. 377:487-505.
28. Muthuchamy, M., P. Rethinasamy, and D.F. Wieczorek. 1997. Tropomyosin structure and function. Trends Cardiovasc. Med. 7:124-128.
29. Gulick, J., T.E. Hewett, R. Klevitsky, S. Buck, R.L. Moss, and J. Robbins. 1997. Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. Circ. Res. 80:655-664.
30. Charron, P., O. Dubourg, M. Desnos, R. Isnard, A. Hagege, G. Bonne, L. Carrier, F. Tesson, J.B. Bouhour, J.C. Buzzi, et al. 1998. Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes. Eur. Heart J. 19:139-145.
31. Seidman, C.E., and J.G. Seidman. 1998. Gene defects that cause inherited cardiomyopathy. In The Molecular Basis of Heart Disease. W.B. Saunders Co., Philadelphia, PA.
32. Watkins, H. 1994. Multiple disease genes cause hypertrophic cardiomyopathy. Br. Heart J. 7296(Suppl.):S4-S9.
33. Geisterfer-Lowrance, A.A., M. Christe, D.A. Conner, J.S. Ingwall, F.J. Schoen, C.E. Seidman, and J.G. Seidman. 1996. A mouse model of familial hypertrophic cardiomyopathy. Science. 272:731-734.
34. Vikstrom, K.L., S.M. Factor, and L.A. Leinwand. 1996. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol. Med. 2:556-567.
35. Ng, W.A., I.L. Grupp, A. Subramaniam, and J. Robbins. 1991. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ. Res. 68:1742-1750.
36. Fewell, J.G., H. Osinska, R. Klevitsky, W.E. Ng, G. Sfyris, F. Bahrehmand, and J. Robbins. 1997. A treadmill exercise regimen for identifying subtle cardiovascular phenotypes in transgenic mice. Am. J. Physiol. 273:H1595-H1605.
37. Jones, W.K., I.L. Grupp, T. Doetschman, G. Grupp, H. Osinska, T.E. Hewett, G. Boivin, J. Gulick, W.A. Ng, and J. Robbins. 1996. Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J. Clin. Invest. 98:1906-1917.
38. Niimura, H., L.L. Bachinski, S. Sangwatanaroj, H. Watkins, A.E. Chudley, W. McKenma, A. Kristinsson, R. Roberts, M. Sole, B.J. Maron, et al. 1998. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N. Engl. J. Med. 338:1248-1257.